Billionaires are betting on anti-ageing research, but can ageing really be cured?
Amazon founder Jeff Bezos has reportedly invested in Altos Labs, a new anti-ageing start-up that hopes to prolong human life.
Investment
Wellcome Sanger Institute Q&A: pushing for a UK genomics revolution
The recently published Genomics Nation report has highlighted the strength and potential of the UK...
Calico and AbbVie: Google-backed partnership re-commits to anti-ageing mission
Calico entered a partnership with global biopharma AbbVie to uncover and market novel treatments for...
VitriVax: one-shot Covid-19 vaccines to improve global access
The biotech start-up is developing technology to compress multi-dose vaccine regimens into one thermostable shot.
Are competition authorities tightening the rules on pharma M&A?
The US Federal Trade Commission has initiated a multilateral working group to ensure that mergers...
AI will be the dominant disrupting technology in upcoming two years: Survey
The pharmaceutical industry is heavily investing in artificial intelligence (AI) to enhance efficiency and deliver pipeline candidates.
AI and Big Data expected to garner maximum investment over next two years
In the past few years, the pharmaceutical industry recorded increasing investment in several emerging technologies for operation enablement and innovation.
How is activity in the pharma sector recovering from Covid-19’s impact?
Analysis of jobs, deals, stock prices and financial filings and news sentiments now show pharma to be a relative winner when it comes to Covid-19 recovery.
Utilisation of RWE can help in managing COVID-19 outbreak: Poll
With COVID-19 pandemic continuing unabated, the opinion of using Real World Evidence (RWE) to control infectious diseases has further gained traction.
Big data and AI are likely to lead emerging technology investments: Survey
With digital transformation gradually picking up pace, the pharmaceutical industry has witnessed an increase in investment in emerging technologies.
Digital transformation: Investment in cybersecurity remain stable
Investment in cybersecurity amid the growing pace of digital transformation has remained relatively stable in the pharmaceutical industry.
